JP2025106358A5 - - Google Patents
Info
- Publication number
- JP2025106358A5 JP2025106358A5 JP2025061016A JP2025061016A JP2025106358A5 JP 2025106358 A5 JP2025106358 A5 JP 2025106358A5 JP 2025061016 A JP2025061016 A JP 2025061016A JP 2025061016 A JP2025061016 A JP 2025061016A JP 2025106358 A5 JP2025106358 A5 JP 2025106358A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- membered
- alkoxy
- oxa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022001804 | 2022-01-07 | ||
| JP2022001804 | 2022-01-07 | ||
| PCT/JP2023/000211 WO2023132369A1 (ja) | 2022-01-07 | 2023-01-06 | Nrf2活性化作用を有する含窒素複素環化合物 |
| JP2023572495A JP7661533B2 (ja) | 2022-01-07 | 2023-01-06 | Nrf2活性化作用を有する含窒素複素環化合物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023572495A Division JP7661533B2 (ja) | 2022-01-07 | 2023-01-06 | Nrf2活性化作用を有する含窒素複素環化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025106358A JP2025106358A (ja) | 2025-07-15 |
| JP2025106358A5 true JP2025106358A5 (cg-RX-API-DMAC7.html) | 2026-01-13 |
Family
ID=87073790
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023572495A Active JP7661533B2 (ja) | 2022-01-07 | 2023-01-06 | Nrf2活性化作用を有する含窒素複素環化合物 |
| JP2025061016A Pending JP2025106358A (ja) | 2022-01-07 | 2025-04-02 | Nrf2活性化作用を有する含窒素複素環化合物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023572495A Active JP7661533B2 (ja) | 2022-01-07 | 2023-01-06 | Nrf2活性化作用を有する含窒素複素環化合物 |
Country Status (17)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR20240325A (es) * | 2022-01-07 | 2024-11-22 | Chugai Pharmaceutical Co Ltd | Compuesto heterocíclico que contiene nitrógeno que tiene un efecto de activación del nrf2 |
| EP4696692A1 (en) * | 2023-06-19 | 2026-02-18 | Chugai Seiyaku Kabushiki Kaisha | Crystal of nitrogen-containing heterocyclic compound having nrf2 activation effect |
| CN118221551A (zh) * | 2024-04-10 | 2024-06-21 | 南京艾康生物科技有限公司 | 4-甲酰苄基氨基甲酸叔丁酯的制备方法 |
| CN119684220A (zh) * | 2024-12-13 | 2025-03-25 | 江苏宝众宝达药业股份有限公司 | 一种(2r,5r)-1,2,5-三甲基哌嗪的制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6326507B1 (en) | 1998-06-19 | 2001-12-04 | Trustees Of Dartmouth College | Therapeutic compounds and methods of use |
| CN102458402B (zh) * | 2009-06-12 | 2013-10-02 | 百时美施贵宝公司 | 用作激酶调节剂的烟酰胺化合物 |
| US20140256767A1 (en) * | 2011-10-31 | 2014-09-11 | The Broad Institute, Inc. | Direct inhibitors of keap1-nrf2 interaction as antioxidant inflammation modulators |
| US9403774B2 (en) * | 2012-10-12 | 2016-08-02 | Bristol-Myers Squibb Company | Guanidine and amine substituted tetrahydroisoquinoline compounds as factor xia inhibitors |
| TWI649330B (zh) | 2013-04-24 | 2019-02-01 | 艾伯維有限公司 | 甲基巴多索龍之2,2-二氟丙醯胺衍生物、其多晶形及其使用方法 |
| US10568876B2 (en) * | 2014-09-05 | 2020-02-25 | Merck Sharp & Dohme Corp. | Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2 |
| US20190380992A1 (en) | 2014-12-04 | 2019-12-19 | Biogen Ma Inc. | Multiple Sclerosis Treatment Regimen Using Dimethyl Fumarate |
| US20190389836A1 (en) * | 2017-01-30 | 2019-12-26 | Biogen Ma Inc. | Nrf2 activator |
| CN110294744A (zh) | 2018-03-21 | 2019-10-01 | 中国医学科学院药物研究所 | Gpr40受体激动剂、其制法和其药物组合物与用途 |
| MY207469A (en) * | 2018-10-22 | 2025-02-27 | C4X Discovery Ltd | Therapeutic compounds |
| KR102932313B1 (ko) * | 2019-02-15 | 2026-02-26 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | Nrf2 활성화제로서 히드록시피리드옥사제핀 |
| GB202005863D0 (en) * | 2020-04-22 | 2020-06-03 | C4X Discovery Ltd | Therapeutic compounds |
| GB202005852D0 (en) * | 2020-04-22 | 2020-06-03 | C4X Discovery Ltd | Therapeutic compounds |
| CN114507181B (zh) * | 2020-11-17 | 2024-03-26 | 中国医学科学院药物研究所 | 含5-取代四氢异喹啉的丙酸类化合物、其药物组合物和应用 |
| CR20240325A (es) * | 2022-01-07 | 2024-11-22 | Chugai Pharmaceutical Co Ltd | Compuesto heterocíclico que contiene nitrógeno que tiene un efecto de activación del nrf2 |
-
2023
- 2023-01-06 CR CR20240325A patent/CR20240325A/es unknown
- 2023-01-06 TW TW112100509A patent/TW202340204A/zh unknown
- 2023-01-06 WO PCT/JP2023/000211 patent/WO2023132369A1/ja not_active Ceased
- 2023-01-06 EP EP23737317.0A patent/EP4446312A4/en active Pending
- 2023-01-06 KR KR1020247025555A patent/KR20240133727A/ko active Pending
- 2023-01-06 IL IL312793A patent/IL312793A/en unknown
- 2023-01-06 PE PE2024001464A patent/PE20241779A1/es unknown
- 2023-01-06 CA CA3246898A patent/CA3246898A1/en active Pending
- 2023-01-06 JP JP2023572495A patent/JP7661533B2/ja active Active
- 2023-01-06 AU AU2023204960A patent/AU2023204960A1/en active Pending
- 2023-01-06 AR ARP230100035A patent/AR128216A1/es unknown
- 2023-01-06 CN CN202380015949.6A patent/CN118488944A/zh active Pending
- 2023-01-06 US US18/726,155 patent/US20250084093A1/en active Pending
- 2023-01-06 MX MX2024008480A patent/MX2024008480A/es unknown
-
2024
- 2024-06-07 CL CL2024001687A patent/CL2024001687A1/es unknown
- 2024-06-19 CO CONC2024/0007707A patent/CO2024007707A2/es unknown
- 2024-08-06 ZA ZA2024/06044A patent/ZA202406044B/en unknown
-
2025
- 2025-01-21 US US19/033,289 patent/US12441735B2/en active Active
- 2025-04-02 JP JP2025061016A patent/JP2025106358A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2023132369A5 (cg-RX-API-DMAC7.html) | ||
| JP2016517878A5 (cg-RX-API-DMAC7.html) | ||
| JPWO2020085493A5 (cg-RX-API-DMAC7.html) | ||
| JP2017515844A5 (cg-RX-API-DMAC7.html) | ||
| IL308165A (en) | Pyrazolyl derivatives as inhibitors of the mutant Kras protein | |
| RU2016146365A (ru) | Новые дигидрохинолизиноны для лечения и профилактики заражения вирусом гепатита b | |
| JP2013515070A5 (cg-RX-API-DMAC7.html) | ||
| JP2023523438A5 (cg-RX-API-DMAC7.html) | ||
| RU2012131129A (ru) | Соединения замещенного n-(1н-индазол-4-ил)имидазол[1,2-а]-3-карбоксамида как ингибиторы cfms | |
| JP2012503018A5 (cg-RX-API-DMAC7.html) | ||
| RU2006111583A (ru) | Производные 1-(2-аминобензол)пиперазина, используемые в качестве ингибиторов поглощения глицина и предназначенные для лечения психоза | |
| JP2009529047A5 (cg-RX-API-DMAC7.html) | ||
| JP2012501312A5 (cg-RX-API-DMAC7.html) | ||
| JP2013523884A5 (cg-RX-API-DMAC7.html) | ||
| JP6695353B2 (ja) | Fgfr4阻害剤としてのホルミル化n−複素環式誘導体 | |
| JP2017505794A5 (cg-RX-API-DMAC7.html) | ||
| CA2749040A1 (en) | Triazolo and tetrazolo pyrimidine derivatives as hne inhibitors for treating copd | |
| RU2017112518A (ru) | Пиридоновые и азапиридоновые соединения и способы применения | |
| RU2016136116A (ru) | Фармацевтические соединения | |
| RU2011107437A (ru) | Ингибиторы кинуренин-3-моноксигеназы | |
| RU2009101911A (ru) | Производные пиридина и пиразина в качестве ингибиторов mnk-киназы | |
| JP2010510319A5 (cg-RX-API-DMAC7.html) | ||
| JP2007501831A5 (cg-RX-API-DMAC7.html) | ||
| JP2015514806A5 (cg-RX-API-DMAC7.html) | ||
| JP2019505595A5 (cg-RX-API-DMAC7.html) |